Suchergebnisse - "Frohme, Carsten"

PubPharm (14)

1

Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment : is there a clinical benefit?

enthalten in: BMC urology | 2014

von Hegele, A. | Knippschild, S. | Frohme, C. | +3

2

Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?

enthalten in: BMC urology | 2014

von Hegele, A. | Knippschild, S. | Frohme, C. | +3

3

Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?

enthalten in: BMC urology | 2014

von Hegele, A. | Knippschild, S. | Frohme, C. | +3

4

TOT approach in stress urinary incontinence (SUI) - outcome in obese female

enthalten in: BMC urology | 2014

von Frohme, C. | Ludt, F. | Varga, Z. | +3

5

TOT Approach in stress urinary incontinence (SUI) – outcome in obese female

enthalten in: BMC urology | 2014

von Frohme, C. | Ludt, F. | Varga, Z. | +3

6

TOT Approach in stress urinary incontinence (SUI) – outcome in obese female

enthalten in: BMC urology | 2014

von Frohme, C. | Ludt, F. | Varga, Z. | +3

7

1948 PROSTAGLANDIN E2 LEVELS IN OAB AND CHANGES AFTER BTX-A THERAPY - A NOVEL BIOMARKER ?

enthalten in: The journal of urology | 2013

von Knippschild, S. | Frohme, C. | Olbert, P. | +2

8

1953 VALUE OF NERVE GROWTH FACTOR LEVELS IN OVERACTIVE BLADDER SYNDROME – ALTERATIONS AFTER BOTULINUM TOXIN THERAPY

enthalten in: The journal of urology | 2012

von Knippschild, S. | Frohme, C. | Olbert, P. | +2

9

Antibodies after botulinum toxin A injection into musculus detrusor vesicae : incidence and clinical relevance

enthalten in: Urologia internationalis | 2011

von Hegele, A. | Frohme, C. | Varga, Z. | +3

10

Charakterisierung der Myc-Funktion durch Miz-1 interaktionsdefiziente Myc-Mutanten

Erschienen: 2010

von Frohme, C.